Chime Biologics is a global Contract Development and Manufacturing Organisation (CDMO) specialising in biologics. The company provides end-to-end solutions to biotech companies, ranging from cell line development to commercial manufacturing, with a focus on innovative, flexible, and high-quality services.

With over 400 skilled employees, Chime Biologics offers integrated services, supporting its clients in bringing life-saving biologic drugs to market efficiently and affordably. The company’s capabilities span multiple stages of the drug development lifecycle, from pre-clinical to commercial manufacturing, ensuring strict compliance with global regulatory standards.

Key Products and Services

• Cell Line Development
• Process Development and Transfer
• Protein Science Characterisation
• Drug Substance Manufacturing
• Drug Product Manufacturing
• Quality Control and Assurance (QC/QA)
• Regulatory Support
• Project Management and Data Integrity

Chime Biologics stands at the forefront of biologics manufacturing, offering robust solutions to empower the success of biotech innovators globally.